[The role of nanotechnology in creating novel antitumor agents]

Vopr Onkol. 2011;57(5):636-40.
[Article in Russian]

Abstract

Nanobiotechnology, defined as an arm of a nano-system is a rapidly developing area of medicine. Nanomaterials ranging from 1 to 1000 nm in size offer unique advantages of interaction with biological systems on the molecular level. Nanobiotechnologies can be used in definition, diagnosis and treatment of cancer thus leading to the new development of a new discipline--nanooncology. The potential of nanoparticles to be used in in-vivo tumor visualization, biomolecular profiling of tumor growth factors and targeted drug delivery is being studied. These methods stemming from nanotechnology may soon find a broad application in oncology.

MeSH terms

  • Anthracyclines / administration & dosage
  • Antineoplastic Agents / administration & dosage*
  • Breast Neoplasms / drug therapy
  • Docetaxel
  • Doxorubicin / administration & dosage
  • Drug Design*
  • Female
  • Humans
  • Liposomes
  • Nanoparticles / therapeutic use
  • Nanostructures / therapeutic use*
  • Nanotechnology / trends*
  • Neoplasms / drug therapy
  • Paclitaxel / administration & dosage
  • Tamoxifen / administration & dosage
  • Taxoids / administration & dosage

Substances

  • Anthracyclines
  • Antineoplastic Agents
  • Liposomes
  • Taxoids
  • Tamoxifen
  • Docetaxel
  • Doxorubicin
  • Paclitaxel